May 9, 2015 | SharpBrains, the Washington, D.C. publisher of maket intelligence, released a new 206-page report that, for the first time, analyzes the major intellectual property trends in the pervasive neurotechnology industry: noninvasive, potentially ubiquitous neurotechnologies, commercially viable outside major medical institutions or research facilities.
Over the past two years a SharpBrains team, crossing the silos of science, intellectual property, technology and business, first identified and then analyzed more than 10,000 patent filings to capture the core themes of a game-changing industry: pervasive neurotechnology. Technology, rooted in neuroscience, designed to monitor brain activity, to change it, and to interface the brain with a wide range of medical, industrial, consumer and computational applications, building on technologies such as electroencephalography (EEG and qEEG), neuro-monitoring, neurocognitive training, transcranial stimulation (TMS and tCDS), virtual reality and more.
“Neurotechnology, our analyis reveals, is going to become pervasive within and beyond the medical domain,” said Alvaro Fernandez, the report’s editor-In-chief. “The number of patent filings in the space is growing at unprecedented rates, and we are proud to offer this unique window into the future for executives, entrepreneurs, researchers, and developers at the forefront of innovation.”
“All too often, neuroscience has been siloed in academia and medical centers, largely absent from mainstream innovation processes. The opportunity with pervasive neurotech is to gain a seat at the big table, to contribute to the future of the digital revolution and human progress,” added Olivier Oullier, professor of behavioral and brain sciences at Aix-Marseille University. To identify key patents and leading IP holders, the SharpBrains team developed a proprietary IP Strength Index, combining quantitative and qualitative criteria. The Leading IP holders in the industry include Nielsen, St. Jude Medical, Medtronic, Microsoft, Brainlab. Posit Science. BodyMedia (Jawbone). Neuronetics. and NeuroPace.
The report is available for $995 for individual users or $2995 for an enterprise license from SharpBrains. For a limited time, purchasers of the report will also receive a free copy of Neurotech Reports’ whitepaper: Brain-Computer Interfaces: A Technology Overview ($195 value). This 27-page report covers the early development of cortical control systems in animal trials and discusses the first commercial products that are now on the market. The report profiles many of the leading research institutions in the U.S. and abroad, and highlights some of the key investigators in the field. The report also discusses the market potential for brain-computer interfaces and looks at several areas of potential application.
To order the SharpBrains report, visit this link. To receive your copy of the whitepaper Brain-Computer Interfaces: A Technology Overview after you have ordered the SharpBrains report, send an email to editor (at) neurotechreports.com. Include the subject line: “SharpBrains Customer”.
